SCHEMBL21361002

SCHEMBL21361002

Cn1c(C(F)F)cc2c(C(=N)NO)ccnc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19880969 0.80 KDM4E (0.32) —
SCHEMBL18638435 0.72 CAMKK1 (0.38) —
SCHEMBL16897077 0.69 CIT (0.39) —
SCHEMBL21361006 0.66 FEN1 (0.36) —
SCHEMBL31337117 0.65 KDM4E (0.44) —
SCHEMBL31701033 0.65 FEN1 (0.32) —
SCHEMBL2125738 0.64 ESR1 (0.40) —
SCHEMBL16692502 0.64 — —
SCHEMBL15645111 0.63 IKBKB (0.41) —
SCHEMBL2123530 0.62 HDAC3 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10414763-B2 Azaquinazoline inhibitors of atypical protein kinase C CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2019-09-17 — — US disclosed
Send feedback